Game Changer
The Investor Using Venture Capital and Machine Learning to Cure Cancer
Andreessen Horowitz’s Vijay Pande is betting that money plus computing power will equal medical breakthroughs.
This article is for subscribers only.
Vijay Pande, a lifelong coder who holds a couple of degrees in physics, doesn’t seem like he’d be the guy to thwart death.
But Pande, a general partner at the venture firm Andreessen Horowitz since 2015, is providing money muscle to computer-powered medical startups including BioAge Labs, which uses genomics data to create anti-aging drugs, and Asimov, which is programming cells to fight disease. (Bloomberg LP, which owns Bloomberg Businessweek, is an investor in Andreessen Horowitz.)